公开(公告)号：US10383917B2

公开(公告)日：2019-08-20

申请号：US15036518

申请日：2014-11-14

Applicant: TOKYO UNIVERSITY OF SCIENCE FOUNDATION

Inventor： Yoichiro Iwakura ,  Masanori Murayama

IPC: A61K38/19

Abstract: Provided is an agent for the treatment of an autoimmune disease, the agent comprising C1q/TNF-related protein 3 (CTRP3), and a method for the treatment of an autoimmune disease, the method comprising: administering an agent, which comprises CTRPb3 for the treatment of an autoimmune disease, to a subject in need of a treatment of an autoimmune disease.

公开(公告)号：US20160287669A1

公开(公告)日：2016-10-06

申请号：US15036518

申请日：2014-11-14

Applicant: TOKYO UNIVERSITY OF SCIENCE FOUNDATION

Inventor： Yoichiro Iwakura ,  Masanori Murayama

IPC: A61K38/19

CPC classification number: A61K38/191

Abstract: Provided is an agent for the treatment of an autoimmune disease, the agent comprising CTRP3, and a method for the treatment of an autoimmune disease, the method comprising: administering an agent, which comprises CTRP3 for the treatment of an autoimmune disease, to a subject in need of a treatment of an autoimmune disease.

Abstract translation: 本发明提供一种治疗自身免疫性疾病的药剂，包含CTRP3的药剂和治疗自身免疫性疾病的方法，该方法包括：向患者施用包含CTRP3的用于治疗自身免疫性疾病的药剂 需要治疗自身免疫性疾病。